Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
29.00
+0.04 (0.14%)
Jun 15, 2026, 10:06 AM EDT - Market open

Immunocore Holdings Revenue

Immunocore Holdings had revenue of $106.68M in the quarter ending March 31, 2026, with 13.63% growth. This brings the company's revenue in the last twelve months to $412.81M, up 23.75% year-over-year. In the year 2025, Immunocore Holdings had annual revenue of $400.02M with 28.95% growth.

Revenue (ttm)
$412.81M
Revenue Growth
+23.75%
P/S Ratio
3.57
Revenue / Employee
$787,809
Employees
524
Market Cap
1.48B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025400.02M89.81M28.95%
Dec 31, 2024310.20M60.77M24.37%
Dec 31, 2023249.43M215.75M640.71%
Dec 31, 202233.67M-2.81M-7.70%
Dec 31, 202136.48M-4.69M-11.39%
Dec 31, 202041.17M7.13M20.95%
Dec 31, 201934.04M3.91M12.98%
Dec 31, 201830.13M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novavax596.34M
Ardelyx427.68M
UroGen Pharma140.49M
Vir Biotechnology65.50M
Monte Rosa Therapeutics42.95M
Capricor Therapeutics11.13M
AtaiBeckley3.49M
Revenue Rankings